Differential expression of miR-873, miR-181a and miR-17-5p and their correlation with immune checkpoints PD-L1 and CD155 among hepatocellular carcinoma patients

被引：1
|
作者：
Eltahtawy, O. [1 ]
Gomaa, A. [2 ]
Youness, R. A. [3 ]
机构：
[1] German Univ Cairo, Mol Genet Res Team, Cairo, Egypt
[2] Natl Liver Inst, Hepatol Dept, Sheben Elkom, Egypt
[3] Univ Hertfordshire, Global Acad Fdn, Sch Life & Med Sci, New Cairo, Egypt
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.annonc.2021.10.046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
30P
引用
收藏
页码：S1385 / S1386
页数：2
相关论文
共 50 条
  • [1] A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma
    Assal, Reem A.
    Elemam, Noha M.
    Mekky, Radwa Y.
    Attia, Abdelrahman A.
    Soliman, Aya Hesham
    Gomaa, Asmaa Ibrahim
    Efthimiadou, Eleni K.
    Braoudaki, Maria
    Fahmy, Sherif Ashraf
    Youness, Rana A.
    TRANSLATIONAL ONCOLOGY, 2024, 45
  • [2] High Expression of Serum miR-17-5p Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Zheng, Jianjian
    Dong, Peihong
    Gao, Shenmeng
    Wang, Ni
    Yu, Fujun
    HEPATO-GASTROENTEROLOGY, 2013, 60 (123) : 549 - 552
  • [3] Increased PD-L1 Expression in Acquired Cisplatin-Resistant Lung Cancer Cells via Mir-181a
    Chen, Yingying
    Song, Wei
    Gao, Yuan
    Dong, Xiu
    Ji, Xinping
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 257 (01): : 33 - 43
  • [4] PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
    Audrito, Valentina
    Serra, Sara
    Stingi, Aureliano
    Orso, Francesca
    Gaudino, Federica
    Bologna, Cinzia
    Neri, Francesco
    Garaffo, Giulia
    Nassini, Romina
    Baroni, Gianna
    Rulli, Eliana
    Massi, Daniela
    Oliviero, Salvatore
    Piva, Roberto
    Taverna, Daniela
    Mandala, Mario
    Deaglio, Silvia
    ONCOTARGET, 2017, 8 (09) : 15894 - 15911
  • [5] Effects of miR-17-5p in Human Hepatocellular Carcinoma Cells by Modulating STAT3 Expression
    Zhang, N.
    Zhang, M.
    Song, H.
    Shen, Z.
    PANCREAS, 2018, 47 (05) : 531 - 531
  • [6] MIR-155-5P PROMOTE TUMOR IMMUNITY BY REGULATING PD-L1 EXPRESSION IN LUNG CANCER CELLS
    Chen, Huan
    Wang, Zhiguo
    Wang, Wei
    Liu, Yigen
    He, Chengzhen
    Chen, Guozhen
    ACTA MEDICA MEDITERRANEA, 2020, 36 (04): : 2385 - 2390
  • [7] Paradoxically functioning onco-miR-155 and the tumor suppressor miR-194 consensus on PD-L1 immune checkpoint upregulation via MALAT-1 and XIST in hepatocellular carcinoma
    Atwa, S.
    Hosny, K.
    Handoussa, H.
    El Tayebi, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S610 - S611
  • [8] Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1
    Yang, Jianru
    Jia, Yang
    Wang, Bing
    Yang, Shengrong
    Du, Kun
    Luo, Yujie
    Li, Yunhe
    Zhu, Bing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients
    Nazila Bostanshirin
    Bahareh Hajikhani
    Amir Abbas Vaezi
    Fatemeh Kermanian
    Fatemeh Sameni
    Somayeh Yaslianifard
    Mehdi Goudarzi
    Masoud Dadashi
    Infectious Agents and Cancer, 18
  • [10] Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients
    Bostanshirin, Nazila
    Hajikhani, Bahareh
    Vaezi, Amir Abbas
    Kermanian, Fatemeh
    Sameni, Fatemeh
    Yaslianifard, Somayeh
    Goudarzi, Mehdi
    Dadashi, Masoud
    INFECTIOUS AGENTS AND CANCER, 2023, 18 (01)
12345